{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:42:28Z","timestamp":1776775348775,"version":"3.51.2"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biopha.2023.114391","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T06:08:11Z","timestamp":1676441291000},"page":"114391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Ivermectin systemic availability in adult volunteers treated with different oral pharmaceutical formulations"],"prefix":"10.1016","volume":"160","author":[{"given":"L.","family":"Ceballos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lifschitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lanusse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114391_bib1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6308762","article-title":"Ivermectin: a potent new antiparasitic agent","volume":"221","author":"Campbell","year":"1983","journal-title":"Science"},{"issue":"6142","key":"10.1016\/j.biopha.2023.114391_bib2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/329752a0","article-title":"Merck's new drug free to WHO for river blindness programme","volume":"329","author":"Lindley","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.114391_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2885.1984.tb00872.x","article-title":"Ivermectin: a review of efficacy and safety","volume":"7","author":"Campbell","year":"1984","journal-title":"J. Vet. Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.114391_bib4","first-page":"469","article-title":"Summary of global update on implementation of preventive chemotherapy against neglected tropical diseases in 2019","volume":"39","year":"2020","journal-title":"Wkly. Epiemiol. Rec."},{"key":"10.1016\/j.biopha.2023.114391_bib5","unstructured":"World Health Organization, 21st Model List of Essential Medicines, Geneva, Switzerland, 2019b, 2021. Available at: \u3008https:\/\/www.who.int\/publications\/i\/item\/WHOMVPEMPIAU2019.06\u3009."},{"issue":"12","key":"10.1016\/j.biopha.2023.114391_bib6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1086\/657310","article-title":"Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial","volume":"51","author":"Knopp","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2023.114391_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006003","article-title":"Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: a community-based pragmatic study","volume":"11","author":"Echaz\u00fa","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2023.114391_bib8","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/jac\/dkz083","article-title":"Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2\u201312 years","volume":"74","author":"Schulz","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2023.114391_bib9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/cid\/ciab365","article-title":"Efficacy and safety of albendazole and high-dose ivermectin co-administration in school-aged children infected with Trichuris trichiura in Honduras: a randomized controlled trial","volume":"73","author":"Matamoros","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"754","key":"10.1016\/j.biopha.2023.114391_bib10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/dkz524","article-title":"Safety of high-dose ivermectin: a systematic review and meta-analysis","volume":"1","author":"Navarro","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2023.114391_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cpt.1219","article-title":"Pharmacokinetics-pharmacodynamics of high-dose ivermectin with dihydroartemisinin-piperaquine on mosquitocidal activity and QT-prolongation (IVERMAL)","volume":"105","author":"Smit","year":"2019","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.114391_bib12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002237994","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"Guzzo","year":"2002","journal-title":"J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2023.114391_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00011-008-8007-8","article-title":"Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice","volume":"57","author":"Zhang","year":"2008","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.biopha.2023.114391_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S0031182005009108","article-title":"Immunomodulatory effect of various anti-parasitics: a review","volume":"132","author":"Sajid","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2023.114391_bib15","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1182\/blood-2010-01-262675","article-title":"The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells","volume":"116","author":"Sharmeen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2023.114391_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2016.06.015","article-title":"IVM exhibits potent antimitotic activity","volume":"226","author":"Ashraf","year":"2016","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.biopha.2023.114391_bib17","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.21873\/anticanres.13669","article-title":"Anti-parasitic drug ivermectin exhibits potent anticancer activity against gemcitabine-resistant cholangiocarcinoma in vitro","volume":"39","author":"Intuyod","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2023.114391_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/653208","article-title":"Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans; the potential of oral insecticides in malaria control","volume":"202","author":"Chaccour","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2023.114391_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.2011.11-0160","article-title":"Ivermectin mass drug administration for humans disrupts malaria parasite transmission in Senegalese villages","volume":"85","author":"Kobylinski","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.biopha.2023.114391_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pt.2011.05.007","article-title":"Endectocides for malaria control","volume":"27","author":"Foy","year":"2011","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.biopha.2023.114391_bib21","article-title":"Plasmodium falciparum signal recognition particle components and antiparasitic efect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP","volume":"16","author":"Panchal","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.114391_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104760","article-title":"The broad spectrum antiviral ivermectin targets the host nuclear transport importin \u03b1\/\u03b21 heterodimer","volume":"177","author":"Yang","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2023.114391_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2013.06.002","article-title":"Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor IVM","volume":"99","author":"Tay","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2023.114391_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"issue":"37","key":"10.1016\/j.biopha.2023.114391_bib25","article-title":"Antiviral effect of high-dose ivermectin in adults with COVID-19: a proof-of-concept randomized trial","volume":"18","author":"Krolewiecki","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.biopha.2023.114391_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0304-4017(93)90115-4","article-title":"Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics","volume":"49","author":"Lanusse","year":"1993","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.biopha.2023.114391_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2885.1994.tb00271.x","article-title":"The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics","volume":"17","author":"Baggot","year":"1994","journal-title":"J. Vet. Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.114391_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.parint.2009.07.006","article-title":"Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice","volume":"58","author":"Ceballos","year":"2009","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.biopha.2023.114391_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.chest.2020.10.009","article-title":"Use of ivermectin is associated with lower mortality in hospitalized patients with coronavirus disease 2019: the ivermectin in COVID nineteen study","volume":"159","author":"Rajter","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2023.114391_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02215150","article-title":"Pharmacokinetic studies of ivermectin: effects of formulation","volume":"9","author":"Lo","year":"1985","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.biopha.2023.114391_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0304-4017(99)00175-2","article-title":"Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle","volume":"87","author":"Lifschitz","year":"2000","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.biopha.2023.114391_bib32","unstructured":"ICH, ICH Q2 (R1) Harmonised tripartite guideline validation of analytical procedures: text and methodology, in: Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Somatek Inc., San Diego, CA, 2014."},{"key":"10.1016\/j.biopha.2023.114391_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/bdd.2510110603","article-title":"MODFIT: a pharmacokinetics computer program","volume":"11","author":"Allen","year":"1990","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.biopha.2023.114391_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2023.114391_bib35","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2741\/4630","article-title":"Drug repurposing approaches to fight Dengue virus infection and related diseases","volume":"23","author":"Botta","year":"2018","journal-title":"Front Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.biopha.2023.114391_bib36","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1093\/cid\/ciaa1341","article-title":"Repurposing ivermectin as an anti-dengue drug","volume":"72","author":"Ooi","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2023.114391_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12936-017-1825-9","article-title":"Ivermectin and malaria control","volume":"16","author":"\u014cmura","year":"2017","journal-title":"Malar. J."},{"issue":"393","key":"10.1016\/j.biopha.2023.114391_bib38","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(18)32613-8","article-title":"Advancing the repurposing of ivermectin for malaria","volume":"13","author":"Chaccour","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.114391_bib39","doi-asserted-by":"crossref","unstructured":"L.E. Lim, C. Vilcheze, C. Ng, W.r. Jr. Jacobs, S. Ramon Garc\u00eda, C. Thompson, Anthelmintic avermectins kill Mycobacterium tuberculosis, including multidrugresistant clinical strains. Antimicrob. Agents Chemother., vol. 57, 2013, pp. 1040\u20136.","DOI":"10.1128\/AAC.01696-12"},{"key":"10.1016\/j.biopha.2023.114391_bib40","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00280-020-04041-z","article-title":"Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug","volume":"85","author":"Juarez","year":"2020","journal-title":"Cancer Chemother. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2023.114391_bib41","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708743","article-title":"P2\u2009\u00d7\u20094 receptor controls microglia activation and favors remyelination in autoimmune encephalitis","volume":"10","author":"Zabala","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.114391_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2885.1996.tb00018.x","article-title":"The effect of level of feed intake on the pharmacokinetic disposition and efficacy of ivermectin in sheep","volume":"19","author":"Ali","year":"1996","journal-title":"J. Vet. Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.114391_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2885.1997.00825.x","article-title":"Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle","volume":"20","author":"Lanusse","year":"1997","journal-title":"J. Vet. Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.114391_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2885.1999.00172.x","article-title":"Bioequivalence of ivermectin formulations in pigs and cattle","volume":"22","author":"Lifschitz","year":"1999","journal-title":"J. Vet. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2023.114391_bib45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/138920009788498969","article-title":"A review of the pharmacological interactions of ivermectin in several animal species","volume":"10","author":"Gonz\u00e1lez-Canga","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2023.114391_bib46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF00637608","article-title":"The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution","volume":"35","author":"Edwards","year":"1988","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2023.114391_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002280050131","article-title":"Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus","volume":"50","author":"Baraka","year":"1996","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2023.114391_bib48","first-page":"203","article-title":"Human pharmacokinetics of orally taken ivermectin","volume":"17","author":"Long","year":"2001","journal-title":"Chin. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2023.114391_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-4017(93)90219-D","article-title":"Effect of formulation on the pharmacokinetics and efficacy of doramectin","volume":"49","author":"Wicks","year":"1993","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.biopha.2023.114391_bib50","doi-asserted-by":"crossref","first-page":"29e30","DOI":"10.1111\/j.1751-0813.1995.tb03472.x","article-title":"The effect of a short-term reduction in feed on the pharmacokinetics and efficacy of albendazole in sheep","volume":"72","author":"Hennessy","year":"1995","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.biopha.2023.114391_bib51","doi-asserted-by":"crossref","first-page":"75e89","DOI":"10.1016\/S0304-4017(00)00320-4","article-title":"Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep","volume":"94","author":"Alvarez","year":"2000","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.biopha.2023.114391_bib52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.exppara.2012.04.014","article-title":"Measurement of ivermectin concentrations in target worms and host gastrointestinal tissues: influence of the route of administration on the activity against resistant Haemonchus contortus in lambs","volume":"131","author":"Lloberas","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.biopha.2023.114391_bib53","first-page":"438","article-title":"The effect of food on the pharmacokinetics of oral ivermectin","volume":"75","author":"Duthaler","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2023.114391_bib54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cpt.1219","article-title":"Pharmacokinetics-pharmacodynamics of high-dose ivermectin with dihydroartemisinin-piperaquine on mosquitocidal activity and QT-prolongation (IVERMAL)","volume":"105","author":"Smit","year":"2019","journal-title":"Clin. Pharm. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2023.114391_bib55","doi-asserted-by":"crossref","first-page":"e586","DOI":"10.1093\/cid\/ciaa1332","article-title":"Ivermectin accelerates circulating nonstructural protein NS1 clerance in adult dengue patients: a combined phase 2\/3 randomized double-blinded placebo controlled trial","volume":"72","author":"Suputtamongkol","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2023.114391_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2885.1994.tb00271.x","article-title":"The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics","volume":"17","author":"Baggot","year":"1994","journal-title":"J. Vet. Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.114391_bib57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vetpar.2017.01.025","article-title":"The route of administration drastically affects ivermectin activity against small strongyles in horses","volume":"236","author":"Saumell","year":"2017","journal-title":"Vet. Parasitol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114391_bib58","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.xphs.2021.01.017","article-title":"Safety and pharmacokinetic assessments of a novel ivermectin nasal spray formulation in a pig model","volume":"110","author":"Errecalde","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.114391_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0304-4017(97)00070-8","article-title":"Comparative pharmacokinetics of doramectin and Ivermectin in cattle","volume":"72","author":"Toutain","year":"1997","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.biopha.2023.114391_bib60","first-page":"407","article-title":"Pharmacokinetics of selamectin in dogs after topical application","volume":"28","author":"Dupuy","year":"2004","journal-title":"Vet. Res."},{"key":"10.1016\/j.biopha.2023.114391_bib61","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1211\/jpp.58.8.0005","article-title":"Sex-related differences in the gastrointestinal disposition of ivermectin in the rat: P-glycoprotein involvement and itraconazole modulation","volume":"58","author":"Lifschitz","year":"2006","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.biopha.2023.114391_bib62","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the bloodbrain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.114391_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.actatropica.2013.03.019","article-title":"The lack of influence of food and local alcoholic brew on the blood level of Mectizan(\u00ae) (ivermectin)","volume":"7","author":"Homeida","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.biopha.2023.114391_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006020","article-title":"Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers","volume":"12","author":"Mu\u00f1oz","year":"2018","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:49:03Z","timestamp":1776772143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223001798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":64,"alternative-id":["S0753332223001798"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114391","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivermectin systemic availability in adult volunteers treated with different oral pharmaceutical formulations","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114391"}}